| PRODUKT |
CATALOG # |
DESCRIPTION |
AMOUNT |
|
sc-3063 |
Synthetic activator of adenylate cyclases more potent at stimulating adenylate cyclases sequence: HSDGIFTDSYRYRLQMAVKKYLAAVLGKRYLQRVKDK (>97% pure by HPLC) |
synthetic activator of adenylate cyclases, 0.5 mg/0.1 ml |
|
sc-3025 |
Substrate |
n/a |
|
sc-3089 |
cyclin degradation. Inhibits Calpain and cathepsin L and B |
synthetic inhibitor of calpain, 0.5 mg/0.1 ml |
|
sc-3062 |
Inhibitor |
|
|
sc-3030 |
Inhibitor |
|
|
sc-3117 |
|
synthetic inhibitor for Autocamtide-2, 0.5 mg/0.1 ml |
|
sc-3037 |
|
synthetic inhibitor of CaM Kinase II, 0.5 mg/0.1 ml |
|
sc-3039 |
|
synthetic inhibitor of CaM Kinase II, 0.5 mg/0.1 ml |
|
sc-3119 |
substrate |
synthetic substrate for CaM Kinase II, 0.5 mg/0.1 ml |
|
sc-3029 |
substrate |
synthetic substrate for CaM Kinase II, 0.5 mg/0.1 ml |
|
sc-3118 |
|
synthetic substrate for CaM Kinase II, 0.5 mg/0.1 ml |
|
sc-3028 |
Substrate |
synthetic substrate for CaM Kinase IV, 0.5 mg/0.1 ml |
|
sc-3120 |
Substrate |
synthetic substrate for casein kinase I, 0.5 mg/0.1 ml |
|
sc-3046 |
Substrate |
synthetic substrate for casein kinase II, 0.5 mg/0.1 ml |
|
sc-3121 |
Substrate |
synthetic substrate for casein kinase II, 0.5 mg/0.1 ml |
|
sc-3068 |
Ac-VAD-cho, Inhibits caspase-1,3,4,7 |
Ac-VAD-cho, Inhibits caspase-1,3,4,7, 0.5 mg/0.1 ml |
|
sc-3070 |
Ac-YVAD-cho, Inhibits caspase-1 and 4 |
Ac-YVAD-cho, Inhibits caspase-1 and 4, 0.5 mg/0.1 ml |
|
sc-3058 |
Substrate |
synthetic substrate for caspase-1 and caspase-4, 0.5 mg/0.1 ml |
|
sc-3073 |
Ac-DEVD-cho, Inhibits caspases-3,6,7,8,10 |
Ac-DEVD-cho, Inhibits caspases-3,6,7,8,10, 0.5 mg/0.1 ml |
|
sc-3076 |
Ac-LEVD-cho, Inhibits caspase-4 |
Ac-LEVD-cho, Inhibits caspase-4, 0.5 mg/0.1 ml |
|
sc-3078 |
z-WHED-fmk, Inhibits caspase-5 |
z-WEHD-fmk, Inhibits caspase-5, 0.5 mg/0.1 ml |
|
sc-3082 |
Ac-IEFD-cho, Inhibits caspase-8 and granzyme B |
Ac-IEFD-cho, Inhibits caspase-8 and granzyme B, 0.5 mg/0.1 ml |
|
sc-3131 |
Z-FA-FMK |
Z-FA-FMK, 0.5 mg |
|
sc-3133 |
Z-RR-AMC |
Z-RR-AMC, 0.5 mg |
|
sc-3134 |
Suc-AAPF-pNA, excellent substrate for the quantitative determination of cathepsin G activity |
Suc-AAPF-pNA, excellent substrate for the quantitative determination of cathepsin G activity, 0.5 mg |
|
sc-3130 |
Z-FG-NHO-Bz, selectively inhibits cathepsins B, L, S and papain |
Z-FG-NHO-Bz, selectively inhibits cathepsins B, L, S and papain, 0.5 mg |
|
sc-3132 |
Z-FY-CHO, a potent and selective inhibitor of cathepsin L |
Z-FY-CHO, a potent and selective inhibitor of cathepsin L, 0.5 mg |
|
sc-3136 |
Z-FR-AMC, excellent substrate for cathepsin L. Also useful as a substrate for cathepsin B |
Z-FR-AMC, excellent substrate for cathepsin L. Also useful as a substrate for cathepsin B, 0.5 mg |
|
sc-3065 |
Substrate |
|
|
sc-3056 |
Substrate |
|
|
sc-3066 |
Substrate |
|
|
sc-3049 |
Substrate |
n/a |
|
sc-362738 |
|
1 mg |
|
sc-3128 |
Substrate |
fluorogenic substrate for measuring the peptidase activity of the 20S proteasome, 0.5 mg/0.1 ml |
|
sc-3129 |
Substrate |
fluorogenic substrate for measuring the peptidase activity of the 20S proteasome, 0.5 mg/0.1 ml |
|
sc-3087 |
Ac-IETD-cho, Inhibits caspase-8 and granzyme B |
Ac-IETD-cho, Inhibits caspase-8 and granzyme B, 0.5 mg/0.1 ml |
|
sc-3114 |
Substrate |
synthetic substrate for GSK-3β, 0.5 mg/0.1 ml |
|
sc-3115 |
Substrate |
synthetic substrate for GSK-3β, 0.5 mg/0.1 ml |
|
sc-3048 |
|
sequence: TRDIYETDYYRK (>97% pure by HPLC) |
|
sc-3560 |
A potent, selective inhibitor of Ca2+calmodulin kinase II. |
1 mg |
|
sc-3141 |
Reversible inhibitor of serine and cysteine proteases such as calpain, plasmin, trypsin, papain, and cathepsin B, no inhibition found with pepsin, cathepsins A and D, thrombin, or α-chymotrypsin; recommended starting concentration 0.5 µg/ml. |
Reversible inhibitor of trypsin-like proteases and cysteine proteases., 0.5 mg/0.1 ml |
|
sc-3013 |
peptide substrate for ERK 1 and ERK 2 MAP kinases, 0.5 mg/0.1 ml |
peptide substrate for ERK 1 and ERK 2 MAP kinases, 0.5 mg/0.1 ml |
|
sc-3011 |
Substrate |
peptide substrate for ERK 1 and ERK 2 MAP kinases, 0.5 mg/0.1 ml |
|
sc-3091 |
Inhibitor |
n/a |
|
sc-3014 |
0.5 mg/0.1 ml |
tyrosine phosphorylation ª 170 µM |
|
sc-3043 |
|
synthetic substrate for MLCK, 0.5 mg/0.1 ml |
|
sc-3045 |
|
synthetic inhibitor for MYLK2, 0.5 mg/0.1 ml |
|
sc-3044 |
|
synthetic substrate for MYLK2, 0.5 mg/0.1 ml |
|
sc-3138 |
synthetic ligand |
synthetic ligand for NK-1R2, 0.5 mg/0.1 ml |
|
sc-3139 |
synthetic ligand |
synthetic ligand for NK-1R3, 0.5 mg/0.1 ml |
|
sc-3140 |
Synthetic potassium channel blocker. Potent vasocon. Reversibly inhibits Ca2+-activated K+ channels in vascular smooth muscle cells. |
Synthetic potassium channel blocker. Potent vasocon, 0.5 mg/0.1 ml |
|
sc-3061 |
synthetic control |
synthetic control for NFκB inhibitor, 0.5 mg/0.1 ml |
|
sc-3060 |
Inhibitor |
synthetic inhibitor for NFκB, 0.5 mg/0.1 ml |
|
sc-3009 |
Substrate |
231-239 (h) |
|
sc-3036 |
|
sequence: KKHTDDGYMPMSPGVA (>97% pure by HPLC) |
|
sc-3010 |
Inhibitor |
N-terminus (h) |
|
sc-3034 |
Synthetic activator of PLA2 derived from PLAP. |
Synthetic activator of PLA2, 0.5 mg/0.1 ml |
|
sc-3055 |
Inhibitor |
synthetic inhibitor for PP2B, 0.5 mg/0.1 ml |
|
sc-3053 |
Substrate |
synthetic substrate for PP2B, 0.5 mg/0.1 ml |
|
sc-3054 |
Substrate |
synthetic substrate for PP2B, 0.5 mg/0.1 ml |
|
sc-3127 |
Inhibitor |
synthetic peptide inhibitor for proteasomes, 0.5 mg/0.1 ml |
|
sc-3142 |
microinjection |
internal (h) |
|
sc-3126 |
Substrate |
n/a |
|
sc-3123 |
|
sequence: TSTEPQYQPGENL (>97% pure by HPLC) |
|
sc-3122 |
Inhibitor |
n/a |
|
sc-3124 |
|
sequence: VPPPVPPRRR (>97% pure by HPLC) |
|
sc-3137 |
|
synthetic ligand for NK-1R, 0.5 mg/0.1 ml |
|
sc-3015 |
Substrate |
n/a |
|
sc-362800 |
|
1 mg |
|
sc-3090 |
Substrate |
n/a |